tiprankstipranks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
ASND
Ascendis Pharma
RESEARCH TOOLSreports
Want to see ASND full AI Analyst Report?

Ascendis Pharma (ASND) Income Statement

696 Followers

Ascendis Pharma Income Statement

Last quarter (Q4 2025), Ascendis Pharma's total revenue was €245.18M, an increase of 40.98% from the same quarter last year. In Q4, Ascendis Pharma's net income was €-33.25M. See Ascendis Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 691.71M€ 363.64M€ 266.72M€ 51.17M€ 7.78M
Gross Profit
€ 588.53M€ 319.38M€ 222.32M€ 39.04M€ 4.25M
Operating Expenses
€ 719.42M€ 598.15M€ 677.86M€ 600.85M€ 456.05M
Depreciation and Amortization
€ 17.00M€ 17.71M€ 18.91M€ 17.51M€ 15.39M
EBITDA
€ -113.90M€ -290.02M€ -411.17M€ -529.18M€ -364.64M
Operating Income
€ -130.89M€ -278.76M€ -455.54M€ -561.81M€ -451.79M
Other Income/Expenses
€ -73.37M€ -94.48M€ -18.60M€ -16.00M€ 67.85M
Pretax Income
€ -204.26M€ -373.24M€ -474.14M€ -577.82M€ -383.94M
Net Income
€ -219.03M€ -378.08M€ -481.45M€ -583.19M€ -383.58M
Per Share Metrics
Basic EPS
€ -3.62€ -6.53€ -8.55€ -10.40€ -7.00
Diluted EPS
€ -3.62€ -6.53€ -8.55€ -10.40€ -7.00
Weighted Average Shares Outstanding
 60.61M 57.89M 56.29M 56.07M 54.77M
Weighted Average Shares Outstanding (Diluted)
 60.61M 57.89M 56.29M 56.07M 54.77M
Currency in EUR

Ascendis Pharma Earnings and Revenue History